30 March 2021

Leprosy/Hansen Disease: Management of reactions and prevention of disabilities

The WHO Global Leprosy Programme has re-released a report with additional information on the use of thalidomide for the treatment of ENL reactions. The guidance supports the use of thalidomide as a ‘steroid-sparing’ medication for ENL.

Visit →